The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

Veteran male athletes who have spent years training at high intensity may be at greater risk of serious heart problems while exercising, new ...

Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering treatments for atrial fibrillation ("AF"), the most common cardiac arrhythmia, today announces enrolment of the first patients ...

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.

From January 6 to 9, CES 2026, held in Las Vegas-brought together 4,112 leading enterprises from around the world. As a ...

The last time I drove a car on the public road was a year ago yesterday, on my way home from the MOT in Ballymena. To ...

The Vocci AI Ring is an audio recorder on your finger. It can record interviews and highlight the important bits without ...

The article 🌱 Patch AM: How a San Clemente High alum is reshaping Arizona’s defense appeared first on San Clemente Patch.